A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy

NCT07628738 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma (Non-Hodgkin's Lymphoma)

Interventions

RADIATION: reduced-intensity radiotherapy

Sponsor

Ruijin Hospital